Bone Marrow Transplantation - Table of Contents alert Volume 49 Issue 11

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 49, Issue 11 (November 2014) In this issue Editorial Review Original Articles Technical Report Letters To The Editor Corrigendum Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement ICB is celebrating its 90th anniversary Have you read these special features published in ICB this year?  The Temporospatial Control of Tfh Cells   NK cell recognition of unconventional ligands  Immunometabolism: The interface of immune and metabolic responses in disease     Editorial Top Autologous GVHD? F Otegbeye, R P Gale and H M Lazarus Bone Marrow Transplant 2014 49: 1349-1351; advance online publication, August 4, 2014; 10.1038/bmt.2014.169 Full Text Review Top An update on allogeneic hematopoietic progenitor cell transplantation for myeloproliferative neoplasms in the era of tyrosine kinase inhibitors K Adekola, U Popat and S O Ciurea Bone Marrow Transplant 2014 49: 1352-1359; advance online publication, August 4, 2014; 10.1038/bmt.2014.176 Abstract | Full Text Original Articles Top LYMPHOMA Allogeneic hematopoietic cell transplantation for mycosis fungoides and Sezary syndrome M J Lechowicz, H M Lazarus, J Carreras, G G Laport, C S Cutler, P H Wiernik, G A Hale, D Maharaj, R P Gale, P A Rowlings, C O Freytes, A M Miller, J M Vose, R T Maziarz, S Montoto, D G Maloney and P N Hari Bone Marrow Transplant 2014 49: 1360-1365; advance online publication, July 28, 2014; 10.1038/bmt.2014.161 Abstract | Full Text PLASMA CELL DISORDERS A phase II study of V-BEAM as conditioning regimen before second auto-SCT for multiple myeloma T-F Wang, M A Fiala, A F Cashen, G L Uy, C N Abboud, T Fletcher, N Wu, P Westervelt, J F DiPersio, K E Stockerl-Goldstein and R Vij Bone Marrow Transplant 2014 49: 1366-1370; advance online publication, July 28, 2014; 10.1038/bmt.2014.163 Abstract | Full Text Bortezomib improves outcome after SCT in multiple myeloma patients with end-stage renal failure I Breitkreutz, C Heiss, A Perne, J Beimler, D Jäger, G Egerer, A D Ho, K Neben, M Zeier, H Goldschmidt and M S Raab Bone Marrow Transplant 2014 49: 1371-1375; advance online publication, August 4, 2014; 10.1038/bmt.2014.165 Abstract | Full Text INHERITED AND GENETIC DISORDERS Hematopoietic SCT for the Black African and non-Black African variants of sickle cell anemia G Lucarelli, A Isgrò, P Sodani, M Marziali, J Gaziev, K Paciaroni, C Gallucci, L Cardarelli, M Ribersani, C Alfieri, G De Angelis, D Armiento, M Andreani, M Testi, A Amato, O O Akinyanju and T T Wakama Bone Marrow Transplant 2014 49: 1376-1381; advance online publication, July 28, 2014; 10.1038/bmt.2014.167 Abstract | Full Text CONDITIONING Sputum cytokine levels in patients undergoing hematopoietic SCT and comparison with healthy subjects and COPD: a pilot study C Moermans, C Bonnet, E Willems, F Baron, M Nguyen, M Henket, J Sele, J-L Corhay, Y Beguin and R Louis Bone Marrow Transplant 2014 49: 1382-1388; advance online publication, July 28, 2014; 10.1038/bmt.2014.164 Abstract | Full Text TRANSPLANT TOXICITIES Incidence and risk factors for moderate-to-severe veno-occlusive disease of the liver after allogeneic stem cell transplantation using a reduced intensity conditioning regimen P D Tsirigotis, I B Resnick, B Avni, S Grisariu, P Stepensky, R Or and M Y Shapira Bone Marrow Transplant 2014 49: 1389-1392; advance online publication, July 28, 2014; 10.1038/bmt.2014.168 Abstract | Full Text Aerobic exercise capacity at long-term follow-up after paediatric allogeneic haematopoietic SCT S Mathiesen, H H Uhlving, F Buchvald, B Hanel, K G Nielsen and K Müller Bone Marrow Transplant 2014 49: 1393-1399; advance online publication, August 11, 2014; 10.1038/bmt.2014.172 Abstract | Full Text BAT2 and BAT3 polymorphisms as novel genetic risk factors for rejection after HLA-related SCT I S Piras, A Angius, M Andreani, M Testi, G Lucarelli, M Floris, S Marktel, F Ciceri, G La Nasa, K Fleischhauer, M G Roncarolo, A Bulfone, S Gregori and R Bacchetta Bone Marrow Transplant 2014 49: 1400-1404; advance online publication, August 11, 2014; 10.1038/bmt.2014.177 Abstract | Full Text Sleep quality following hematopoietic stem cell transplantation: longitudinal trajectories and biobehavioral correlates A M Nelson, C L Coe, M B Juckett, M E Rumble, P J Rathouz, P Hematti and E S Costanzo Bone Marrow Transplant 2014 49: 1405-1411; advance online publication, August 18, 2014; 10.1038/bmt.2014.179 Abstract | Full Text GRAFT-VERSUS-HOST DISEASE Salvage therapy with everolimus reduces the severity of treatment-refractory chronic GVHD without impairing disease control: A dual center retrospective analysis S Mielke, M Lutz, J Schmidhuber, M Kapp, D Ditz, J Ammer, H Einsele, G U Grigoleit, E Holler and D Wolff Bone Marrow Transplant 2014 49: 1412-1418; advance online publication, August 4, 2014; 10.1038/bmt.2014.170 Abstract | Full Text DONOR SAFETY Deferrals of volunteer stem cell donors referred for evaluation for matched-unrelated stem cell donation S Bräuninger, K Thorausch, B Luxembourg, M Schulz, K U Chow, E Seifried and H Bonig Bone Marrow Transplant 2014 49: 1419-1425; advance online publication, August 4, 2014; 10.1038/bmt.2014.171 Abstract | Full Text QOL AND PATIENTS' CARE Quality of life and outcomes in patients60 years of age after allogeneic hematopoietic cell transplantation B K Hamilton, L Rybicki, J Dabney, L McLellan, H Haddad, L Foster, D Abounader, M Kalaycio, R Sobecks, R Dean, H Duong, B T Hill, B J Bolwell and E A Copelan Bone Marrow Transplant 2014 49: 1426-1431; advance online publication, July 28, 2014; 10.1038/bmt.2014.166 Abstract | Full Text Technical Report Top Analysis of post-transplant chimerism by using a single amplification reaction of 38 Indel polymorphic loci A Santurtún, J A Riancho, L Yañez, M Santurtún and M T Zarrabeitia Bone Marrow Transplant 2014 49: 1432-1435; advance online publication, August 11, 2014; 10.1038/bmt.2014.173 Abstract | Full Text Letters To The Editor Top Conservative management of pneumatosis intestinalis after allogeneic hematopoietic SCT P K Bhamidipati, A Ghobadi, S Bauer, J F DiPersio and I Pusic Bone Marrow Transplant 2014 49: 1436-1438; advance online publication, July 21, 2014; 10.1038/bmt.2014.148 Full Text Association between mobilization regimen and PFS after auto-SCT for multiple myeloma A L Garfall, A L Dougherty, D T Vogl, B M Weiss, A D Cohen, R Mick, U O'Doherty and E A Stadtmauer Bone Marrow Transplant 2014 49: 1439-1441; advance online publication, July 21, 2014; 10.1038/bmt.2014.153 Full Text A retrospective multi-centre study of the effects of allogeneic haematopoietic SCT on pulmonary function R Dharmagunawardena, R M Pearce, G Thomas, K Kirkland, J Perry, J F Apperley, P Medd, K M O Wilson, K Orchard, G Jackson, J A Snowden, G Cook and J S Brown on behalf of the British Society of Blood and Marrow Transplantation, Clinical Trials Committee Bone Marrow Transplant 2014 49: 1442-1443; advance online publication, July 21, 2014; 10.1038/bmt.2014.154 Full Text Improvement of high serum levels of biomarkers of endothelial injury after allogeneic hematopoietic SCT with pre-existing severe hepatitis using recombinant human soluble thrombomodulin T Saito, Y Inoue, K Sato, Y Tsuruoka, R Shigefuku, H Ikeda, C Okuse, M Takahashi and I Miura Bone Marrow Transplant 2014 49: 1444-1445; advance online publication, July 28, 2014; 10.1038/bmt.2014.156 Full Text Successful hematopoietic cell transplantation in patients with unique NF-κB essential modulator (NEMO) mutations J K Abbott, R R Quinones, M T de la Morena and E W Gelfand Bone Marrow Transplant 2014 49: 1446-1447; advance online publication, July 28, 2014; 10.1038/bmt.2014.157 Full Text Angioedema in patients treated with sirolimus and ACE inhibitor post hematopoietic SCT M Jung, V N Ranpura, C E Dunbar, J F Tisdale, C D Fitzhugh and M M Hsieh Bone Marrow Transplant 2014 49: 1448-1449; advance online publication, July 28, 2014; 10.1038/bmt.2014.162 Full Text Tracheobronchomalacia after allogeneic BMT; pulmonary function test findings similar to those of bronchiolitis obliterans J Watanabe, K Sato, Y Fujikura, T Horiuchi, S Kato, R Hikota, T Maekawa, T Yamamura, A Kobayashi, S Kobayashi, A Kawana and F Kimura Bone Marrow Transplant 2014 49: 1450-1451; advance online publication, August 18, 2014; 10.1038/bmt.2014.175 Full Text Corrigendum Top BAT2 and BAT3 polymorphisms as novel genetic risk factors for rejection after HLA-related SCT I S Piras, A Angius, M Andreani, M Testi, G Lucarelli, M Floris, S Marktel, F Ciceri, G La Nasa, K Fleischhauer, M G Roncarolo, A Bulfone, S Gregori and R Bacchetta Bone Marrow Transplant 2014 49: 1452; 10.1038/bmt.2014.241 Full Text Advertisement Have you read this highly downloaded review article recently published in Clinical & Translational Immunology? Improved mouse models to assess tumour immunity and irAEs after combination cancer immunotherapies Clinical application of genetically modified T cells in cancer therapy  Browse and read more open access contents.     Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Bone Marrow Transplantation. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2014 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.